Almac Group: Clinical Trial Shipping Service

New Almac Pod service addresses the changing global dynamics of temperature-controlled shipping.

Almac Group, the global contract development and manufacturing organization, has recognized the need for a change in dynamics of temperature-controlled shipping with the launch of its new Almac Pod™ service in the U.S.

Understanding the cost, logistical and compliance challenges posed by this changing environment, the Almac Pod was originally released in Europe and serves as a first-to-market service solution.It incorporates the efficiencies of the Almac-approved, global courier network and advanced phase-change material technology (PCM) to create a temperature-controlled shipping service solution that eases the burden for its global clinical supply customers.

The Almac Pod is protected, optimized and dynamic, safeguarding customers’ products and mitigating against temperature excursions of all clinical shipments and is aimed to be used for biologics or difficult-to-handle products. Since launching the service, the Almac Pod has been 100% effective in protecting the integrity of shipped products with no known temperature excursions within the shipper qualification period.

Almac Pod has now been expanded for use in temperature-controlled shipping services in the U.S., and internationally.

The Almac Pod is fully GDP-compliant and is available as part of Almac’s end-to-end, global supply chain management solutions.

Companies in this article
More in Home